アリゾナ州におけるCOPDの臨床試験
アリゾナ州内の拠点で、COPDに関する17件の研究が参加者を募集しています。
アリゾナ州内の都市
公式研究テキスト（英語）
WIN Ratio Analysis to Determine a Strategy of Non- Invasive SUpport for Respiratory Failure in the EmeRgency Department
- Banner University Medical Center Tucson, Tucson
被験者募集中
18歳以上 · 全性別 · 2026/10/01更新 · NCT07558265Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic Phenotype
- Tucson Clinical Research Institute- Site Number : 8400006, Tucson
被験者募集中第3相
40歳〜80歳 · 全性別 · 2026/10/01更新 · NCT07190222To Evaluate the Effect of EXPD-101/FXS7553 Compared With Placebo in Patients With COPD Over 52 Weeks of Treatment
- DM Clinical Research - Phoenix, Phoenix
被験者募集中第2相
40歳〜85歳 · 全性別 · 2026/09/30更新 · NCT07684820Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD) Characterized by an Eosinophilic Phenotype
- Chandler Clinical Research Trials- Site Number : 8400025, Chandler
- Pulmonary Associates - Phoenix - East Bell Road- Site Number : 8400114, Phoenix
- Epic Medical Research - Surprise- Site Number : 8400096, Surprise
被験者募集中第3相
40歳〜80歳 · 全性別 · 2026/09/22更新 · NCT07190209An Evaluation of the AeriSeal System for CONVERTing Collateral Ventilation Status in Patients With Severe Emphysema
- Banner University Medical Center, Phoenix
被験者募集中
40歳〜80歳 · 全性別 · 2026/09/17更新 · NCT06035120A Study to Investigate the Effect of AZD6793 in Participants With Moderate to Very Severe Chronic Obstructive Pulmonary Disease
- Research Site, Phoenix
- Research Site, Phoenix
- Research Site, Phoenix
被験者募集中第2相
40歳以上 · 全性別 · 2026/09/09更新 · NCT07082738Clinical Trial of Omalizumab for Allergen Sensitized and Exposed Individuals With COPD
- University of Arizona- Tuscon, Tucson
被験者募集中第2相
40歳以上 · 全性別 · 2026/09/04更新 · NCT07059091A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00007)
- Research Site, Phoenix
- Research Site, Scottsdale
被験者募集中第3相
40歳〜80歳 · 全性別 · 2026/09/03更新 · NCT06878261A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00006)
- Research Site, Phoenix
- Research Site, Phoenix
被験者募集中第3相
40歳〜80歳 · 全性別 · 2026/09/03更新 · NCT06883305A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate to Severe Chronic Obstructive Pulmonary Disease
- Chandler Clinical Trials, Chandler
- Pulmonary Associates, PA, Phoenix
被験者募集中第2/3相
35歳〜80歳 · 全性別 · 2026/08/31更新 · NCT07363694A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease
- Research Site, Gilbert
- Research Site, Mesa
- Research Site, Mesa
- 他2件
被験者募集中第3相
40歳〜80歳 · 全性別 · 2026/08/26更新 · NCT06283966A Non-inferiority Pharmacokinetic and Safety/Tolerability Study of Two Different Doses of Weekly SC Alpha1-PI 15% Compared With Corresponding Standard IV Alpha1-PI in Participants With Alpha1-Antitrypsin Deficiency (AATD)
- GC2501 Study Site 102, Phoenix
- GC2501 Study Site 107, Scottsdale
被験者募集中第3相
18歳〜80歳 · 全性別 · 2026/08/11更新 · NCT07555483STRIVE Post-Market Registry Study
- Dignity Health St. Joseph's Hospital and Medical Center, Phoenix
被験者募集中観察研究
18歳以上 · 全性別 · 2026/08/03更新 · NCT04302272SPIROMICS Study of Early COPD Progression (SOURCE)
- Mayo Clinic Arizona, Scottsdale
被験者募集中観察研究健康なボランティア歓迎
30歳〜55歳 · 全性別 · 2026/06/03更新 · NCT05033990Pulmonary Rehabilitation for Rural Patients With COPD
- Mayo Clinic in Arizona, Scottsdale
被験者募集中
40歳以上 · 全性別 · 2026/05/07更新 · NCT06847061Bronchoscopic RElease of Air Trapped in Hyperinflated Emphysematous Lung - Study 3
- Banner Health, Gilbert
被験者募集中
40歳〜84歳 · 全性別 · 2026/04/24更新 · NCT06891755myAirvo 3 (High Flow Nasal Therapy; HFNT) for COPD Patients in the Home
- Honor Health, Scottsdale
被験者募集中
30歳以上 · 全性別 · 2025/02/06更新 · NCT05204888ClinicalTrials.govより、2026/10/02時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。